HGH Fragment 176-191
Also known as: HGH Frag 176-191, Fragment 176-191, hGH 176-191, Growth Hormone Fragment 176-191
Synthetic 16-amino-acid peptide corresponding to the C-terminal region (residues 176-191) of human growth hormone, stabilized by a disulfide bridge between its two cysteine residues. It was developed at Monash University (Australia) to isolate growth hormone's lipolytic activity: it is reported to stimulate fat breakdown and inhibit lipogenesis while lacking the growth-promoting and insulin-antagonizing effects of full-length GH, since it does not meaningfully activate the GH receptor or raise IGF-1. It is not FDA-approved for any human indication and exists as a research/grey-market compound; the related Tyr-modified analog AOD-9604 failed to meet primary endpoints in an obesity clinical trial.
Who's worth your money for HGH Fragment 176-191
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
Average price
$6.25/mg
Sellers
4
45-day trend
-11.8%
2 of 4 sellers have a current price· 1 stale hidden· 1 unverified hidden
- No fresh prices — all 1 listing are older than 7 days.
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
Watch HGH Fragment 176-191
Get one email when the market actually moves — no newsletter, no noise.
About HGH Fragment 176-191
CAS
—
Molecular formula
C80H127N23O24S2
Sequence
YLRIVQCRSVEGSCGF
Typical dose range
250-500 mcg/day subcutaneous (vendor/anecdotal norms; no established clinical dosing)
Half-life
Short; reported on the order of minutes in plasma (limited human pharmacokinetic data)
Common research uses
Safety notes
Not FDA-approved for human therapeutic use; sold as a research chemical in most jurisdictions. Human efficacy and long-term safety data are limited. WADA does not list this specific fragment by name, but growth-hormone fragments and GH-modulating agents fall in a scrutinized class for athletes.
Reconstitution
Reconstitute lyophilized powder with bacteriostatic water; refrigerate after reconstitution and protect from light.
COAs for HGH Fragment 176-191
7 third-party tests across 6 vendors. Each card links to the full report.
For
HGH Frag. 176-191
by Moglabs· batch HGF001
For
Fragment 176-191
by Ion Peptide· batch F176-121325
For
HGH
by Licensed Peptides· batch 102420
For
HGH-FRAG
by Kimera Chems· batch Green Cap
For
HGH Fragment
by Verified Peptides
For
FRAG176
by Peptide Tech
For
HGH Fragment 176-191
by Peptidology· batch 1200014
1 citations indexed for HGH Fragment 176-191
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.